TD Private Client Wealth LLC Grows Holdings in HCA Healthcare, Inc. (NYSE:HCA)

TD Private Client Wealth LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 33.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,130 shares of the company’s stock after purchasing an additional 1,545 shares during the quarter. TD Private Client Wealth LLC’s holdings in HCA Healthcare were worth $1,840,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MML Investors Services LLC boosted its stake in HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after acquiring an additional 4,285 shares during the last quarter. Meritage Group LP purchased a new position in HCA Healthcare in the third quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC purchased a new position in HCA Healthcare in the fourth quarter valued at about $18,044,000. Alpha DNA Investment Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at approximately $869,000. Finally, NRI Wealth Management LC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at approximately $2,896,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 1.3 %

NYSE:HCA opened at $329.25 on Friday. The company has a 50-day moving average price of $321.50 and a 200-day moving average price of $343.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $81.06 billion, a price-to-earnings ratio of 14.99, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business posted $5.90 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. Bank of America dropped their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, Morgan Stanley decreased their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $385.67.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.